DaVita HealthCare Partners Inc. (NYSE:DVA) – Equities research analysts at KeyCorp dropped their FY2017 earnings per share (EPS) estimates for shares of DaVita HealthCare Partners in a research report issued on Monday. KeyCorp analyst J. Gurda now forecasts that the brokerage will post earnings per share of $3.50 for the year, down from their prior estimate of $3.76. KeyCorp also issued estimates for DaVita HealthCare Partners’ FY2018 earnings at $3.96 EPS.

DaVita HealthCare Partners (NYSE:DVA) last released its quarterly earnings data on Wednesday, November 2nd. The company reported $0.95 EPS for the quarter, beating the consensus estimate of $0.93 by $0.02. DaVita HealthCare Partners had a net margin of 4.92% and a return on equity of 16.16%. The business earned $3.73 billion during the quarter, compared to the consensus estimate of $3.72 billion. During the same quarter in the prior year, the firm earned $1.12 EPS. The business’s revenue was up 5.8% on a year-over-year basis.

WARNING: This article was originally posted by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another publication, it was illegally copied and reposted in violation of US and international copyright & trademark law. The correct version of this article can be viewed at http://www.dailypolitical.com/2017/01/13/fy2017-eps-estimates-for-davita-healthcare-partners-inc-dva-cut-by-analyst.html.

Earnings History and Estimates for DaVita HealthCare Partners (NYSE:DVA)

Several other equities research analysts also recently commented on DVA. Wells Fargo & Company reiterated an “outperform” rating on shares of DaVita HealthCare Partners in a research note on Tuesday, November 1st. Jefferies Group reiterated a “buy” rating and set a $70.00 price objective (down from $86.00) on shares of DaVita HealthCare Partners in a research note on Saturday, November 19th. Zacks Investment Research raised shares of DaVita HealthCare Partners from a “strong sell” rating to a “hold” rating in a report on Friday, November 4th. Robert W. Baird cut shares of DaVita HealthCare Partners from an “outperform” rating to a “neutral” rating and raised their target price for the stock from $68.00 to $69.00 in a report on Tuesday, December 13th. Finally, SunTrust Banks, Inc. set a $66.00 target price on shares of DaVita HealthCare Partners and gave the stock a “hold” rating in a report on Thursday, October 13th. Ten research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $74.00.

DaVita HealthCare Partners (NYSE:DVA) traded up 0.98% on Wednesday, hitting $64.03. 275,665 shares of the company’s stock traded hands. The stock has a 50-day moving average of $64.59 and a 200-day moving average of $66.53. The stock has a market cap of $12.64 billion, a PE ratio of 18.66 and a beta of 1.04. DaVita HealthCare Partners has a one year low of $54.50 and a one year high of $78.77.

Several hedge funds have recently added to or reduced their stakes in the company. Checchi Capital Advisers LLC boosted its stake in DaVita HealthCare Partners by 2.4% in the second quarter. Checchi Capital Advisers LLC now owns 1,556 shares of the company’s stock worth $120,000 after buying an additional 37 shares in the last quarter. Calvert Investment Management Inc. boosted its stake in DaVita HealthCare Partners by 0.6% in the second quarter. Calvert Investment Management Inc. now owns 10,300 shares of the company’s stock worth $796,000 after buying an additional 57 shares in the last quarter. First Allied Advisory Services Inc. boosted its stake in DaVita HealthCare Partners by 1.2% in the second quarter. First Allied Advisory Services Inc. now owns 7,712 shares of the company’s stock worth $592,000 after buying an additional 94 shares in the last quarter. Sii Investments Inc. WI boosted its stake in DaVita HealthCare Partners by 3.2% in the second quarter. Sii Investments Inc. WI now owns 3,984 shares of the company’s stock worth $308,000 after buying an additional 124 shares in the last quarter. Finally, FDx Advisors Inc. boosted its stake in DaVita HealthCare Partners by 0.6% in the second quarter. FDx Advisors Inc. now owns 23,743 shares of the company’s stock worth $1,836,000 after buying an additional 134 shares in the last quarter. 83.08% of the stock is owned by institutional investors and hedge funds.

WARNING: This article was originally posted by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another publication, it was illegally copied and reposted in violation of US and international copyright & trademark law. The correct version of this article can be viewed at http://www.dailypolitical.com/2017/01/13/fy2017-eps-estimates-for-davita-healthcare-partners-inc-dva-cut-by-analyst.html.

DaVita HealthCare Partners Company Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, is a provider of kidney care services. The Company operates Kidney Care division and HealthCare Partners (HCP) division. The Company’s segments include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives.

5 Day Chart for NYSE:DVA

Receive News & Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.